List of Tables
    Table 1. Selective Cox-2 Inhibitors Market Opportunities & Trends in Global Market
    Table 2. Selective Cox-2 Inhibitors Market Drivers in Global Market
    Table 3. Selective Cox-2 Inhibitors Market Restraints in Global Market
    Table 4. Key Players of Selective Cox-2 Inhibitors in Global Market
    Table 5. Top Selective Cox-2 Inhibitors Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Selective Cox-2 Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Selective Cox-2 Inhibitors Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Selective Cox-2 Inhibitors Product Type
    Table 9. List of Global Tier 1 Selective Cox-2 Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Selective Cox-2 Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Selective Cox-2 Inhibitors Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Selective Cox-2 Inhibitors Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Selective Cox-2 Inhibitors Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Selective Cox-2 Inhibitors Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Selective Cox-2 Inhibitors Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Selective Cox-2 Inhibitors Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2023-2028
    Table 30. Boehringer-Ingelheim Corporate Summary
    Table 31. Boehringer-Ingelheim Selective Cox-2 Inhibitors Product Offerings
    Table 32. Boehringer-Ingelheim Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 33. TerSera Therapeutics Corporate Summary
    Table 34. TerSera Therapeutics Selective Cox-2 Inhibitors Product Offerings
    Table 35. TerSera Therapeutics Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 36. Iroko Pharmaceuticals Corporate Summary
    Table 37. Iroko Pharmaceuticals Selective Cox-2 Inhibitors Product Offerings
    Table 38. Iroko Pharmaceuticals Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 39. Apotex Corporate Summary
    Table 40. Apotex Selective Cox-2 Inhibitors Product Offerings
    Table 41. Apotex Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 42. Yung Shin Pharmaceutical Corporate Summary
    Table 43. Yung Shin Pharmaceutical Selective Cox-2 Inhibitors Product Offerings
    Table 44. Yung Shin Pharmaceutical Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 45. Breckenridge Pharmaceutical Corporate Summary
    Table 46. Breckenridge Pharmaceutical Selective Cox-2 Inhibitors Product Offerings
    Table 47. Breckenridge Pharmaceutical Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 48. Meda Pharmaceuticals Corporate Summary
    Table 49. Meda Pharmaceuticals Selective Cox-2 Inhibitors Product Offerings
    Table 50. Meda Pharmaceuticals Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 51. Cipla Corporate Summary
    Table 52. Cipla Selective Cox-2 Inhibitors Product Offerings
    Table 53. Cipla Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 54. Glenmark Pharmaceuticals Corporate Summary
    Table 55. Glenmark Pharmaceuticals Selective Cox-2 Inhibitors Product Offerings
    Table 56. Glenmark Pharmaceuticals Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 57. Teva Corporate Summary
    Table 58. Teva Selective Cox-2 Inhibitors Product Offerings
    Table 59. Teva Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 60. PuraCap Pharmaceutical Corporate Summary
    Table 61. PuraCap Pharmaceutical Selective Cox-2 Inhibitors Product Offerings
    Table 62. PuraCap Pharmaceutical Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 63. Almirall Limited Corporate Summary
    Table 64. Almirall Limited Selective Cox-2 Inhibitors Product Offerings
    Table 65. Almirall Limited Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 66. Lupin Pharmaceuticals Corporate Summary
    Table 67. Lupin Pharmaceuticals Selective Cox-2 Inhibitors Product Offerings
    Table 68. Lupin Pharmaceuticals Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 69. Aurobindo Pharma Corporate Summary
    Table 70. Aurobindo Pharma Selective Cox-2 Inhibitors Product Offerings
    Table 71. Aurobindo Pharma Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 72. Pfizer Corporate Summary
    Table 73. Pfizer Selective Cox-2 Inhibitors Product Offerings
    Table 74. Pfizer Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 75. Mylan Corporate Summary
    Table 76. Mylan Selective Cox-2 Inhibitors Product Offerings
    Table 77. Mylan Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 78. Takeda Corporate Summary
    Table 79. Takeda Selective Cox-2 Inhibitors Product Offerings
    Table 80. Takeda Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 81. Bayer Corporate Summary
    Table 82. Bayer Selective Cox-2 Inhibitors Product Offerings
    Table 83. Bayer Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 84. Novacap Corporate Summary
    Table 85. Novacap Selective Cox-2 Inhibitors Product Offerings
    Table 86. Novacap Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 87. Abbott Corporate Summary
    Table 88. Abbott Selective Cox-2 Inhibitors Product Offerings
    Table 89. Abbott Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 90. Geri-Care Corporate Summary
    Table 91. Geri-Care Selective Cox-2 Inhibitors Product Offerings
    Table 92. Geri-Care Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 93. Perrigo Corporate Summary
    Table 94. Perrigo Selective Cox-2 Inhibitors Product Offerings
    Table 95. Perrigo Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 96. Kopran Corporate Summary
    Table 97. Kopran Selective Cox-2 Inhibitors Product Offerings
    Table 98. Kopran Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 99. Merck Corporate Summary
    Table 100. Merck Selective Cox-2 Inhibitors Product Offerings
    Table 101. Merck Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 102. Hengrui pharmaceutical Corporate Summary
    Table 103. Hengrui pharmaceutical Selective Cox-2 Inhibitors Product Offerings
    Table 104. Hengrui pharmaceutical Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 105. Kelun Group Corporate Summary
    Table 106. Kelun Group Selective Cox-2 Inhibitors Product Offerings
    Table 107. Kelun Group Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 108. Qilu Pharmaceutical Corporate Summary
    Table 109. Qilu Pharmaceutical Selective Cox-2 Inhibitors Product Offerings
    Table 110. Qilu Pharmaceutical Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 111. Taro Pharmaceuticals  Corporate Summary
    Table 112. Taro Pharmaceuticals  Selective Cox-2 Inhibitors Product Offerings
    Table 113. Taro Pharmaceuticals  Selective Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Selective Cox-2 Inhibitors Segment by Type in 2021
    Figure 2. Selective Cox-2 Inhibitors Segment by Application in 2021
    Figure 3. Global Selective Cox-2 Inhibitors Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Selective Cox-2 Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Selective Cox-2 Inhibitors Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Selective Cox-2 Inhibitors Revenue in 2021
    Figure 8. By Type - Global Selective Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Selective Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Selective Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Selective Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 12. US Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Selective Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 16. Germany Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 17. France Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Selective Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 24. China Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 28. India Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Selective Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 30. Brazil Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Selective Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 33. Turkey Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Selective Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 37. Boehringer-Ingelheim Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. TerSera Therapeutics Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Iroko Pharmaceuticals Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Apotex Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Yung Shin Pharmaceutical Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Breckenridge Pharmaceutical Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Meda Pharmaceuticals Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Cipla Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Glenmark Pharmaceuticals Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Teva Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. PuraCap Pharmaceutical Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Almirall Limited Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Lupin Pharmaceuticals Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Aurobindo Pharma Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Pfizer Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. Mylan Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. Takeda Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. Bayer Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 55. Novacap Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 56. Abbott Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 57. Geri-Care Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 58. Perrigo Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 59. Kopran Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 60. Merck Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 61. Hengrui pharmaceutical Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 62. Kelun Group Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 63. Qilu Pharmaceutical Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 64. Taro Pharmaceuticals  Selective Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)